home / stock / allr / allr news

ALLR News and Press, Allarity Therapeutics Inc. From 07/11/22

Stock Information
Company Name: Allarity Therapeutics Inc.
Stock Symbol: ALLR
Market: NASDAQ
Website: allarity.com
Menu
ALLR ALLR Quote ALLR Short ALLR News ALLR Articles ALLR Message Board
Get ALLR Alerts

News, Short Squeeze, Breakout and More Instantly...
ALLR - Allarity Therapeutics Bolsters Its Board of Directors with Appointment of Prominent Clinical Researcher and Oncology Drug Developer, David A. Roth, M.D.

Interim CEO James G. Cullem, J.D. and Co-Founder Thomas Jensen also joining the Board Press Release Cambridge, MA , U.S.A . ( Ju ly 11 , 2022 ) — Allarity Therapeutics, Inc. (“Allarity” ...
ALLR - Alpha Tau, Precigen top healthcare gainers; Revelation, Nemaura lead losers' pack

Gainers: Alpha Tau Medical ( DRTS ) +42% . Precigen ( PGEN ) +20% . Amylyx Pharmaceuticals ( AMLX ) +18% . bluebird bio ( BLUE ) +13% . Talaris Therapeutics ( TALS ) +11% . Losers: Revelation Biosciences ( REVB ...

ALLR - Allarity Therapeutics appoints interim CEO, CFO

The board of clinical-stage pharmaceutical company Allarity Therapeutics ( NASDAQ: ALLR ) appointed Chief Business Officer James Cullem interim CEO and Director of Financial Reporting Joan Brown interim CFO, with immediate effect. Former CEO Steve Carc...

ALLR - Allarity Therapeutics Strengthens Scientific Advisory Board with Appointment of Distinguished Oncologist Roberto Pili, M.D.

Cambridge, MA U.S.A . ( June 15 , 202 2 ) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP ...
ALLR - Mirati, CymaBay top healthcare gainers; Verastem, Delcath lead losers' pack

Gainers: Mirati Therapeutics (MRTX) +23%. CymaBay Therapeutics (CBAY) +16%. Veru (VERU) +9%. Kodiak Sciences (KOD) +8%. Allarity Therapeutics (ALLR) +7%. Losers: Verastem (VSTM) -12%. Delcath Systems (DCTH) -11%. Vicarious Surgical (RBOT) -8%. CEL-...

ALLR - Allarity Therapeutics GAAP EPS of -$0.56

Allarity Therapeutics press release (NASDAQ:ALLR): Q1 GAAP EPS of -$0.56. As of March 31, 2022, Allarity’s cash was $14.5 million, as compared to $19.6 million as of December 31, 2021. For further details see: Allarity Therapeutics GAAP EPS of -$0.56

ALLR - Allarity Therapeutics Reports First Quarter 2022 Financial Results

Cambridge, MA U.S.A. ( May 27 , 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP ® companion diagn...
ALLR - AVDL, SIGA, PSHG and IOVA among mid-day movers

Gainers: Avadel Pharmaceuticals (AVDL) +123%. SIGA Technologies (SIGA) +40%. Concert Pharmaceuticals (CNCE) +30%. Farfetch (FTCH) +25%. Allarity Therapeutics (ALLR) +25%. Merus N.V. (MRUS) +23%. Tenon Medical (TNON) +22%. Arcturus Therapeutics Holdings (ARCT) +19%. Red Rob...

ALLR - Top Penny Stocks Today: What's Moving AVDL, BKSY, NILE, INO, & ALLR

When it comes to penny stocks to buy , most are usually looking for day trading opportunities. That means time frames are shorter term, in general. If you’re new to trading cheap stocks, you might be thinking about investing in them because of their low price. But it’s als...

ALLR - Avadel, PMV Pharmaceuticals top healthcare gainers; Iovance, SpringWorks lead losers' pack

Gainers: Avadel Pharmaceuticals AVDL +61%. PMV Pharmaceuticals PMVP +25%. Alpha Tau Medical (DRTS) +18%. SIGA Technologies SIGA +18%. Allarity Therapeutics (ALLR) +17%. Losers: Iovance Biotherapeutics (IOVA) -54%. SpringWorks Therapeutics SWTX...
Previous 10 Next 10